Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness.
HCV education
direct-acting antiviral therapy
hepatitis C
homelessness
substance use
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
12
11
2021
accepted:
28
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
The objective of this study was to evaluate the effectiveness of formal hepatitis C virus (HCV) education on engagement in therapy in persons experiencing homelessness in an on-site shelter-based model of care. As policies to eliminate Medicaid access restrictions to HCV treatment are expanded, patient education is paramount to achieving HCV elimination targets in difficult-to-engage populations including persons experiencing homelessness. This prospective study was conducted at 4 shelters in San Francisco and Minneapolis from August 2018 to January 2021. Of the 162 HCV Ab-positive participants, 150 participated in a 30-minute HCV education session. Posteducation changes in knowledge, beliefs, barriers to care, and willingness to accept therapy scores were assessed. Following education, knowledge scores (mean change, 4.4 ± 4.4; An HCV educational intervention successfully increased willingness to engage in HCV therapy in persons experiencing homelessness in an on-site shelter-based HCV model of care.
Sections du résumé
Background
UNASSIGNED
The objective of this study was to evaluate the effectiveness of formal hepatitis C virus (HCV) education on engagement in therapy in persons experiencing homelessness in an on-site shelter-based model of care. As policies to eliminate Medicaid access restrictions to HCV treatment are expanded, patient education is paramount to achieving HCV elimination targets in difficult-to-engage populations including persons experiencing homelessness.
Methods
UNASSIGNED
This prospective study was conducted at 4 shelters in San Francisco and Minneapolis from August 2018 to January 2021. Of the 162 HCV Ab-positive participants, 150 participated in a 30-minute HCV education session. Posteducation changes in knowledge, beliefs, barriers to care, and willingness to accept therapy scores were assessed.
Results
UNASSIGNED
Following education, knowledge scores (mean change, 4.4 ± 4.4;
Conclusions
UNASSIGNED
An HCV educational intervention successfully increased willingness to engage in HCV therapy in persons experiencing homelessness in an on-site shelter-based HCV model of care.
Identifiants
pubmed: 35369281
doi: 10.1093/ofid/ofac103
pii: ofac103
pmc: PMC8968162
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofac103Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK026743
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Aliment Pharmacol Ther. 2013 Apr;37(7):703-9
pubmed: 23432436
Am J Public Health. 1997 Feb;87(2):217-20
pubmed: 9103100
Dig Dis Sci. 2020 Oct;65(10):3023-3031
pubmed: 31974916
Liver Int. 2013 Aug;33(7):999-1007
pubmed: 23509897
Hepatol Commun. 2020 Jan 14;4(3):355-370
pubmed: 32140654
Hepatol Commun. 2020 Mar 03;4(5):646-656
pubmed: 32363316
Curr Opin Psychol. 2015 Oct 1;5:85-89
pubmed: 26258160
J Behav Health Serv Res. 2014 Jan;41(1):37-49
pubmed: 23616250
PLoS One. 2018 Apr 11;13(4):e0195575
pubmed: 29641546
Prev Med. 2010 Jan-Feb;50(1-2):63-7
pubmed: 19716379
Dig Dis Sci. 2011 Jan;56(1):213-9
pubmed: 20972850
Clin Infect Dis. 2014 Nov 15;59(10):1411-9
pubmed: 25114031
Lancet Public Health. 2021 May;6(5):e309-e323
pubmed: 33780656
J Community Health. 2019 Dec;44(6):1044-1054
pubmed: 31127412
BMC Infect Dis. 2014 Feb 10;14:74
pubmed: 24512462
Prev Chronic Dis. 2014 May 01;11:E72
pubmed: 24784908
J Health Soc Behav. 2000 Mar;41(1):50-67
pubmed: 10750322
Addict Behav. 2017 Sep;72:21-26
pubmed: 28342409
Public Health Rep. 2012 Jul-Aug;127(4):407-21
pubmed: 22753984
J Health Psychol. 2017 Sep;22(10):1300-1311
pubmed: 26857543
BMC Infect Dis. 2020 May 29;20(1):386
pubmed: 32471376
J Community Health. 2007 Aug;32(4):221-30
pubmed: 17696047
Hepatology. 2019 Mar;69(3):1020-1031
pubmed: 30398671
Aliment Pharmacol Ther. 2019 Jul;50(1):66-74
pubmed: 31115920
J Viral Hepat. 2018 Nov;25(11):1260-1269
pubmed: 29851232
Scand J Caring Sci. 2009 Dec;23(4):801-8
pubmed: 19500309
Drug Alcohol Depend. 2018 Apr 1;185:411-420
pubmed: 29477574
Hepatol Commun. 2022 Jan;6(1):50-64
pubmed: 34628726
Public Health Rep. 2017 Mar/Apr;132(2):136-139
pubmed: 28135425
Lancet Infect Dis. 2012 Nov;12(11):859-70
pubmed: 22914343
Lancet. 2011 Jun 25;377(9784):2205-14
pubmed: 21676456
J Health Care Poor Underserved. 2012 May;23(2):811-33
pubmed: 22643626
J Gen Intern Med. 2002 Feb;17(2):134-43
pubmed: 11841529
Dig Dis Sci. 2021 Feb;66(2):434-441
pubmed: 32239377
Public Health Rep. 2020 Jul/Aug;135(1_suppl):44S-49S
pubmed: 32735189